Editas Medicine Inc (EDIT)
5.62
+0.16
(+3.02%)
USD |
NASDAQ |
May 02, 16:00
5.63
+0.01
(+0.18%)
After-Hours: 16:00
Editas Medicine Price to Book Value: 1.317 for May 2, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 01, 2024 | 1.278 |
| April 30, 2024 | 1.221 |
| April 29, 2024 | 1.258 |
| April 26, 2024 | 1.247 |
| April 25, 2024 | 1.223 |
| April 24, 2024 | 1.254 |
| April 23, 2024 | 1.280 |
| April 22, 2024 | 1.312 |
| April 19, 2024 | 1.287 |
| April 18, 2024 | 1.301 |
| April 17, 2024 | 1.315 |
| April 16, 2024 | 1.371 |
| April 15, 2024 | 1.425 |
| April 12, 2024 | 1.455 |
| April 11, 2024 | 1.542 |
| April 10, 2024 | 1.554 |
| April 09, 2024 | 1.643 |
| April 08, 2024 | 1.575 |
| April 05, 2024 | 1.575 |
| April 04, 2024 | 1.596 |
| April 03, 2024 | 1.608 |
| April 02, 2024 | 1.61 |
| April 01, 2024 | 1.706 |
| March 28, 2024 | 1.739 |
| March 27, 2024 | 1.744 |
| Date | Value |
|---|---|
| March 26, 2024 | 1.692 |
| March 25, 2024 | 1.725 |
| March 22, 2024 | 1.751 |
| March 21, 2024 | 1.835 |
| March 20, 2024 | 1.856 |
| March 19, 2024 | 1.816 |
| March 18, 2024 | 1.809 |
| March 15, 2024 | 1.905 |
| March 14, 2024 | 1.91 |
| March 13, 2024 | 2.013 |
| March 12, 2024 | 2.018 |
| March 11, 2024 | 2.109 |
| March 08, 2024 | 2.147 |
| March 07, 2024 | 2.074 |
| March 06, 2024 | 2.128 |
| March 05, 2024 | 2.142 |
| March 04, 2024 | 2.325 |
| March 01, 2024 | 2.468 |
| February 29, 2024 | 2.358 |
| February 28, 2024 | 2.594 |
| February 27, 2024 | 2.076 |
| February 26, 2024 | 1.889 |
| February 23, 2024 | 1.830 |
| February 22, 2024 | 1.857 |
| February 21, 2024 | 1.876 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.221
Minimum
Apr 30 2024
14.40
Maximum
Jan 08 2021
3.962
Average
3.662
Median
Price to Book Value Benchmarks
| Vertex Pharmaceuticals Inc | 5.878 |
| Moderna Inc | 3.473 |
| Amicus Therapeutics Inc | 19.21 |
| Geron Corp | 8.677 |
| Regeneron Pharmaceuticals Inc | 3.963 |
Price to Book Value Related Metrics
| PS Ratio | 5.462 |
| Price | 5.62 |
| Earnings Yield | -36.48% |
| Market Cap | 459.79M |